Breast Surgery ROI Target high-volume breast cancer centers and community hospitals to adopt Lumicell Direct Visualization System, emphasizing reduced re-excisions and shorter OR times with a clear ROI for hospital leadership and payers.

Expansion Beyond Breast Position LumiSystem as a pan-oncologic imaging platform to explore other solid tumor indications; propose pilots at academic centers and cancer institutes to accelerate multi-site adoption and data generation.

Commercial Growth Leverage strong funding and new leadership (Chief Commercial Officer) to accelerate enterprise deals; align sales motions with IDNs, health systems, and surgeon networks to scale multi-site deployments.

Clinical Engagement Capitalize on ASBrS 2026 presence and ongoing surgeon outreach to deepen adoption; establish clinician-led studies, KOL advisory boards, and case-based education to accelerate evidence generation and uptake.

Education Partnerships Expand collaborations with Learn Look Locate and similar education partners to raise awareness and drive demand through joint training, webinars, and co-marketing that creates a pipeline of informed buyers.